A wrist device cut Tourette's tics by a quarter in a UK trial
⏮ BeforePeople with Tourette's had limited options to reduce tic frequency beyond existing treatments.
✅ NowA prototype wrist device, Neupulse, reduced tic frequency by an average of 25 percent in a 2023 UK trial.
In short
- A 2023 UK clinical trial tested a prototype wrist device on 121 people.
- Tic frequency fell by an average of 25 percent among users.
- The device, called Neupulse, came out of research at the University of Nottingham.
Why it's good news
Tics can be disruptive for people with Tourette's in school, work and daily life. This prototype was tested in a clinical trial rather than only in a lab. The source reports that users describe benefits three years on, though the detail of that follow-up is not given here.
Advertisement
From The Optimist Daily
BY THE OPTIMIST DAILY EDITORIAL TEAM In a 2023 clinical trial of 121 people in the UK, wearing a prototype wrist device reduced tic frequency by an average of 25 percent. The Tourette’s wrist device, called Neupulse, came out of research at the University of Nottingham, and three years on, the people using it describe […] The post This Tourette’s wrist device cut tics by a quarter in a UK trial first appeared on The Optimist Daily: Making Solutions the News .
Ask this story
More like this
Advertisement